Antioxidant therapy has been investigated as a potential approach for fatty liver disease
Horiguchi, T
And now I understand better what you're saying about the pulse effect when people were taking, or I don't know what they were using in the original studies, but if a person takes an IV, they get this initial boost because it's there, but then they break it down so then you don't see it, and then it rebuilds it up again, which again, if you're, you know, aging and have other taxors and, you know, aren't efficient at producing glutathione, I guess you could take, you know, all this, all these glutathione IVs in the world, and it could be difficult for you to actually reconstitute it into the glutathione that you need
Rega, N
PMID: 60 ZhaoHChenSCaoNWuWLiuGGaoJet al
Nevertheless, the use of APAP in babies and young children, which was a relatively uncommon occurrence half a century ago, is now extremely common